Adjuvant bisphosphonates in breast cancer: the ABCSG-12 study

Affiliations

¹ Department of Orthopaedic Surgery, Center for Orthopaedic Research, Barton Research Institute and Department of Physiology and Biophysics, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA. suvalarryj@uams.edu

Comment

Larry J Suva. Curr Osteoporos Rep. 2010 Jun.

. 2010 Jun;8(2):57-9.

doi: 10.1007/s11914-010-0012-5.

¹ Department of Orthopaedic Surgery, Center for Orthopaedic Research, Barton Research Institute and Department of Physiology and Biophysics, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA. suvalarryj@uams.edu

No abstract available

Comment on

Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
Gnant M, Mlineritsch B, Schippinger W, Luschin-Ebengreuth G, Pöstlberger S, Menzel C, Jakesz R, Seifert M, Hubalek M, Bjelic-Radisic V, Samonigg H, Tausch C, Eidtmann H, Steger G, Kwasny W, Dubsky P, Fridrik M, Fitzal F, Stierer M, Rücklinger E, Greil R; ABCSG-12 Trial Investigators; Marth C. Gnant M, et al. N Engl J Med. 2009 Feb 12;360(7):679-91. doi: 10.1056/NEJMoa0806285. N Engl J Med. 2009. PMID: 19213681 Clinical Trial.